Breaking Breaking
CNBC Business

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

myndfocal
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Error scraping article: [Errno 2] No such file or directory: '/tmp/.newspaper_scraper/article_resources'

— Source: CNBC Business (https://www.cnbc.com/2026/06/08/novo-nordisk-eli-lilly-obesity-pills-medicare-coverage.html)

Business
Read original on CNBC Business →